iJOBS Company Visit to Campus: Merck Process Research & Development (PR&D) Enabling Technologies (ET)

Event Description

The Process Research & Development (PR&D) Enabling Technologies (ET) group at Merck is kicking off recruitment for 2026. To provide more information on ET, it is composed of 3 groups—Data-Rich Experimentation, Chemical Biotechnologies, and Continuous & Expression Technologies—that develop cutting-edge technologies to address current and future problems in Merck's small molecule, biologics, and vaccine pipelines. This group spans a range of research areas including synthetic chemistry, technology development to enable data-dense solutions, biocatalysis & protein engineering, flow chemistry, and microbial production. Anne Marie Crooke, PhD and Cecilia Bottecchia, PhD will be visiting Rutgers to give an overview in a group information session followed by individual meetings with students and postdocs who are interested in applying for roles with PR&D ET. We will be collecting the resumes/CVs of those who want to be considered for individual meetings and scheduling times for later that day.

Upcoming Events